Editorial
Accepted on 08 Sep 2025
Editorial: Bone Marrow Aging and Its Impact on Immunosenescence in Neurological Diseases
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1697136
Type at least 3 characters
1,423 articles
Mini Review
Published on 05 Sep 2025
C/EBPβ as a master regulator of inflammasome signaling in neurodegenerative diseases: mechanisms and therapeutic implications
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1656165
- 515 views
Review
Published on 05 Sep 2025
Neuro-immune axis in atherosclerosis: mechanisms of regulation and therapeutic opportunities
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1619338
- 523 views
Original Research
Published on 04 Sep 2025
Association of systemic inflammatory factors with clinical outcomes in patients with autoimmune encephalitis at different clinical stages
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1632690
- 657 views
Original Research
Published on 03 Sep 2025
Gut mycobiota dysbiosis and systemic immune dysfunction in Chinese schizophrenia patients with metabolic syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1652633
- 555 views
Original Research
Accepted on 29 Aug 2025
Human pluripotent stem cell-derived neuronal progenitor cells improve motor function and promote neurogenesis in a stroke model
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1650092
- 620 views
Review
Published on 29 Aug 2025
Neuro-immune interactions in coronary microvascular disease: mechanisms and therapeutic prospect
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1631083
- 1,836 views
Systematic Review
Published on 29 Aug 2025
Effects of breathing training on walking ability and quality of life in patients with multiple sclerosis: systematic review and meta-analysis of randomized controlled trials
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1643938
- 801 views
Original Research
Accepted on 27 Aug 2025
Exploratory Study on Autoantibodies to Arginine-rich Human Peptides Mimicking Epstein-Barr Virus in Women with Post-COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1650948
- 1,039 views
Review
Published on 27 Aug 2025
Neurotrophic factors in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1654603
- 826 views
Mini Review
Accepted on 26 Aug 2025
Rediscovering Parainfectious Encephalopathy in the Post-COVID-19 Era
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1634383
- 600 views
Review
Published on 26 Aug 2025
Bidirectional crosstalk between microglia and serotonin signaling in neuroinflammation and CNS disorders
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1646740
- 997 views
Original Research
Published on 26 Aug 2025
Amygdala volume changes as a potential marker of multiple sclerosis progression: links to EDSS scores and PIRA
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1640607
- 691 views
Original Research
Accepted on 25 Aug 2025
Anti-neuronal and anti-mitochondrial autoantibodies are associated with lower functional status and more severe respiratory symptoms in post COVID syndrome
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1642250
- 519 views
Original Research
Published on 21 Aug 2025
Discovery and early validation of serum protein signatures in untreated multiple sclerosis patients: identification of candidate biomarkers for diagnosis and stratification
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1579045
- 662 views
Editorial
Published on 20 Aug 2025
Editorial: Use of big data and artificial intelligence in multiple sclerosis
in Multiple Sclerosis and Neuroimmunology
Frontiers in Immunology
doi 10.3389/fimmu.2025.1679482
- 993 views